Catabolism of lipid-free recombinant apolipoprotein serum amyloid A by mouse macrophages in vitro results in removal of the amyloid fibril-forming amino terminus

Scandinavian Journal of Immunology

Volumn 48, Issue 3, 1998, Pages 241-247

  Elliott Bryant, R ^a,b   Liang, J S ^b   Sipe, J D ^b   Cathcart, E S ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; APOLIPOPROTEIN; RECOMBINANT PROTEIN;

AMYLOIDOSIS; ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; FEMALE; LIPOPROTEIN METABOLISM; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SPLEEN CELL; TISSUE INJURY;

AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEINS; FEMALE; LIPID METABOLISM; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SPLEEN;

EID: 0031694813     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00384.x     Document Type: Article

References (38)

1. McAdam KPW, Elin RJ, Sipe JD, Wolff SM. Changes in human serum amyloid A and C-reactive protein following etiocholanlolone-induced inflammation. J Clin Invest 1978;61:390-4.
2. Anders RF, Nordstoga K, Natvig JB, Husby G. Amyloid-treated serum protein SAA in endotoxin-induced amyloidosis in the mink. J Exp Med 1976;143:678-86.
3. Levin M, Franklin EC, Frangione B, Pras M. The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest 1972;51:2773-9.
4. Husebekk A, Skogen B, Husby G, Marhaug G. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol 1985;21:263-8.
5. Westermark GT, Engstrom U, Westermark P. The N-terminal segment of protein AA determines its fibrillogenic property. Biochem Biophys Res Comm 1992;182:27-33.
6. de Beer MC, de Beer FC, McCubbin WD, Kay CM, Kindy MS. Structural prerequisites for serum amyloid A fibril formation. J Biol Chem 1993;268:20606-12.
7. Kisilevsky R, Narindrasorasak S, Tape C, Tan R, Boudreau L. During AA amyloidogenesis is proteolytic attack on serum amyloid A a pre- or post-fibrillogenic event? Amyloid 1994;1:174-83.
8. Lavie G, Zucker-Franklin D, Franklin EC. Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes. J Exp Med 1978;148:1020-31.
9. Lavie G, Zucker-Franklin D, Franklin EC. Elastase-type proteases on the surface of human blood monocyte: Possible role in amyloid formation. J Immunol 1980;125:175-80.
10. Zucker-Franklin D, Lavie G, Franklin EC. Demonstration of membrane bound proteolytic activity on the surface of mononuclear leukocytes. J Histochem Cytochem 1981;29:451-6.
11. Shephard EG, de Beer FC, de Beer MC, Jeenah GA, van der Westhuyzen DR. Neutrophil association and degradation of normal and acute-phase high-density lipoprotein 3. Biochem J 1987;248: 919-26.
12. Silverman SL, Cathcart ES, Skinner MS, Cohen AS. The degradation of serum amyloid A protein by activated polymorphonuclear leukocytes: participation of granulocytic elastase. Immunol 1982;46: 737-44.
13. Skogen B, Thorsteinsson L, Natvig JB. Degradation of protein SAA to an AA-like fragment by enzymes of monocytic origin. Scand J Immunol 1980;11:533-40.
14. Skogen B, Natvig JB. Degradation of amyloid proteins by different serine proteases. Scand J Immunol 1981;14:391-8.
15. Bausserman LL, Herbert PN. Degradation of serum amyloid A and apolipoproteins by serum proteases. Biochem 1984;23:2241-5.
16. Elliott-Bryant R, Liang J-S, Sipe JD, Cathcart ES. Degradation of serum amyloid A in amyloid-susceptible and amyloid-resistant mouse strains. Scand J Immunol 1996;44:223-8.
17. Elliott-Bryant R, Sipe JD, Gonnerman WA, Newcombe DS, Cathcart ES. In vitro clearance of HDL associated SAA by resident peritoneal cells from CBA/J mice. In: Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle T, Young ID, eds. Amyloid and Amyloidosis 1993. New York: Parthenon Press, 1994:119-21.
18. Palm M, Holm Nielsen E, Svehag S-E. An in vitro cellular system for generation of AA amyloid. APMIS 1997;105:603-8.
19. Hoffman JS, Benditt EP. Changes in high density lipoprotein content following endotoxin administration in the mouse: formation of serum amyloid protein-rich subtractions. J Biol Chem 1982;257: 10510-7.
20. Polacek D, Byrne RE, Fless GM, Scanu AM. In vitro proteolysis of human plasma low density lipoproteins by an elastase released from human blood polymorphonuclear cells. J Biol Chem 1986;261: 2057-63.
21. Ericsson LH, Eriksen N, Walsh KA, Benditt EP. Primary structure of duck protein A. FEBS Lett 1987;218:11-6.
22. Westermark P, Sletten K, A serum AA-like protein as a common constituent of secondary amyloid fibrils. Clin Exp Immunol 1982; 49:725-31.
23. Arai K, Miura K, Baba S, Shirasawa H. Transformation from SAA2-tibrils to AA-fibrils in amyloid librillogenesis: in vivo observations in murine spleen using anti-SAA and anti-AA antibodies. J Pathol 1994;173:127-34.
24. Yamada T, Kluve-Beckerman B, Liepnieks JJ, Benson MD. Fibril formation from recombinant human serum amyloid A. Biochim Biophys Acta 1994;1226:323-9.
25. Bausserman LL, Herbert PN, Rodger R, Nicolosi RJ. Rapid clearance of serum amyloid A from high density lipoproteins. Biochim Biophys Acta 1984;792:186-91.
26. Tape C, Kisilevsky R. Apolipoprotein A-1 and apolipoprotein SAA half-lives during acute inflammation and amyloidogenesis. Biochem Biophys Acta 1990;1043:295-300.
27. Brinckerhoff CE, Mitchell TI, Karmilowicz, MJ, Kluve-Beckerman B, Benson MD. Autocrine induction of collagenase by serum amyloid-A like and beta 2-microglobulin-like proteins. Science 1989;243:655-7.
28. Mitchell TI, Coon CI, Brinckerhoff CE. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin I induces synthesis of collagenase and is neutralized with specific antiserum. J Clin Invest 1995;87:1177-85.
29. Mitchell TI, Jeffrey JJ, Palmitier RD, Brinckerhoff CE. The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin. Biochim Biophys Acta 1993;1156:245-54.
30. Kumon Y, Sipe JD, Brinckerhoff CE, Schreiber BM. Interleukin-1 (induces apolipoprotein serum amyloid A3 (apoSAA3) synthesis and secretion by cultured neonatal rabbit aotic smooth muscle muscle cells. Scand J Immunol 1997;46:284-91.
31. Dwulet FE, Benson MD. Primary structure of amyloid fibril protein AA in azocasein-induced amyloidosis of CBA/J mice. J Lab Clin Med 1987;110:322-9.
32. Axelrad MA, Kisilevsky R, Willmer J, Skinner M, Cohen AS. Further characterization of amyloid-enhancing factor. Lab Invest 1982;47:139-46.
33. Elliott-Bryant R, Cathcart ES. Apolipoprotein E and apolipoprotein A-1 knock-out mice readily develop amyloid A protein amyloidosis. Clin Immunol Immunopathol 1997;85:104-8.
34. Sipe JD, Gonnerman WA, Loose LD, Knapschaefer G, Xie W-J, Franzblau C. Direct binding solid phase ELISA for serum amyloid A (SAA). J Immunol Meth 1989;125:125-35.
35. Webb NR, de Beer MC, van der Westhuzen DR et al. Adenoviral vector-mediated overexpression of serum amyloid A on apoA-1-deficient mice. J Lipid Res 1997;38:1583-90.
36. Fuks A, Zucker-Franklin D. Impaired Kupffer cell function precedes development of secondary amyloidosis. J Exp Med 1985;148: 1013-28.
37. Herbert L, Janousek J, Gervais F. In vitro uptake of HDL-SAA by tissue macrophages during the development of AA amyloidosis in mice. Amyloid 1995;2:251-6.
38. Patel H, Bramall J, Waters H, de Beers MC, Woo P. Expression of recombinant human serum amyloid A in mamalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis. Biochem J 1996;318:1041-9.